DC
ACOR

Deere & Company’s Acorda Therapeutics ACOR Stock Holding History

Deere & Company’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-187
Closed -$573K – 1112
2016
Q2 		$573K Buy
187
+5
+3% +$16.3K 0.03% 545
2016
Q1 		$579K Buy
182
+124
+214% +$515K 0.03% 515
2015
Q4 		$299K Sell
58
-506
-90% -$2.21M 0.02% 715
2015
Q3 		$1.8M Hold
564
– – 0.11% 192
2015
Q2 		$2.26M Buy
564
+23
+4% +$88.8K 0.12% 172
2015
Q1 		$2.16M Buy
541
+441
+441% +$2.02M 0.12% 184
2014
Q4 		$488K Sell
100
-100
-50% -$429K 0.03% 626
2014
Q3 		$815K Sell
200
-36
-15% -$135K 0.05% 441
2014
Q2 		$954K Buy
+236
New +$962K 0.05% 391

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Deere & Company's ACOR Position: Q3 2016 in Review

Deere & Company sold out of Acorda Therapeutics (ACOR) in Q3 2016, closing a stake of 187 shares — an estimated $573K sold.

Deere & Company first reported a position in ACOR in Q2 2014 and held it in 9 quarters. The position peaked at $2.26M in Q2 2015. 167 funds tracked by Wall St. Rank hold ACOR as of Q3 2016.

  • Deere & Company reported no remaining Acorda Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 187 Acorda Therapeutics shares in Q3 2016, an estimated $573K.
  • Deere & Company first reported a position in Acorda Therapeutics in Q2 2014 and held it in 9 quarters.
  • Deere & Company's Acorda Therapeutics position peaked at $2.26M in Q2 2015.
  • 167 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.